Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Faviprevir in COVID-19 Treatment
NCT04351295Phase 3Completed
- Sponsor
- Tanta University
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by Tanta University. Started Apr 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04351295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351295.